55 related articles for article (PubMed ID: 10700830)
1. Repeated 131I treatment of a residual ovarian teratoma containing malignant thyroid tissue.
Suga K; Hirabayashi A; Motoyama K; Kume N; Matsunaga N; Tamura H; Kato H
Br J Radiol; 1999 Nov; 72(863):1110-3. PubMed ID: 10700830
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human thyrotropin for the diagnosis and treatment of a highly functional metastatic struma ovarii.
Rotman-Pikielny P; Reynolds JC; Barker WC; Yen PM; Skarulis MC; Sarlis NJ
J Clin Endocrinol Metab; 2000 Jan; 85(1):237-44. PubMed ID: 10634393
[TBL] [Abstract][Full Text] [Related]
3. Early change of thyroid hormone concentration after 131I treatment in patients with solitary toxic adenoma.
Pirnat E; Fidler V; Zaletel K; Gaberscek S; Hojker S
Nuklearmedizin; 2002; 41(4):178-83. PubMed ID: 12224401
[TBL] [Abstract][Full Text] [Related]
4. [Malignant transformation of thyroid tissue in an ovarian dermoid cyst: case report].
Krnojelac D; Hadzić B; Curcin N; Dolai M; Bogdanović G
Med Pregl; 1999; 52(9-10):395-8. PubMed ID: 10624391
[TBL] [Abstract][Full Text] [Related]
5. Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment.
Bachelot A; Leboulleux S; Baudin E; Hartl DM; Caillou B; Travagli JP; Schlumberger M
Clin Endocrinol (Oxf); 2005 Mar; 62(3):376-9. PubMed ID: 15730423
[TBL] [Abstract][Full Text] [Related]
6. Incidental scintigraphic finding of ovarian teratoma containing normal thyroid tissue on post-radioactive iodine therapy for papillary thyroid cancer.
Gauthé M; Kelly A; Dejax C; Cachin F; Bourdel N
Clin Nucl Med; 2013 Jun; 38(6):467-8. PubMed ID: 23531739
[TBL] [Abstract][Full Text] [Related]
7. Sequential changes in serum thyroid peroxidase following radioiodine therapy of patients with differentiated thyroid carcinoma.
Ozata M; Bayhan H; Bingöl N; Dündar S; Beyhan Z; Corakci A; Gundogan MA
J Clin Endocrinol Metab; 1995 Dec; 80(12):3634-8. PubMed ID: 8530612
[TBL] [Abstract][Full Text] [Related]
8. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer.
Ozata M; Suzuki S; Miyamoto T; Liu RT; Fierro-Renoy F; DeGroot LJ
J Clin Endocrinol Metab; 1994 Jul; 79(1):98-105. PubMed ID: 8027262
[TBL] [Abstract][Full Text] [Related]
9. Follicular carcinoma of the thyroid with functioning metastases and clinical hyperthyroidism.
McConnon JK; von Westarp C; Mitchell RI
Can Med Assoc J; 1975 Mar; 112(6):724-5,727. PubMed ID: 1122444
[TBL] [Abstract][Full Text] [Related]
10. Coexistence of malignant struma ovarii and cervical papillary thyroid carcinoma.
Leong A; Roche PJ; Paliouras M; Rochon L; Trifiro M; Tamilia M
J Clin Endocrinol Metab; 2013 Dec; 98(12):4599-605. PubMed ID: 24217901
[TBL] [Abstract][Full Text] [Related]
11. Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease.
Nakazato N; Yoshida K; Mori K; Kiso Y; Sayama N; Tani JI; Nakagawa Y; Ito S
Thyroid; 1999 Aug; 9(8):775-9. PubMed ID: 10482369
[TBL] [Abstract][Full Text] [Related]
12. Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.
Saint-Vil D; Emran MA; Lambert R; Alos N; Turpin S; Huot C
J Pediatr Surg; 2007 May; 42(5):853-6. PubMed ID: 17502198
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ
J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514
[TBL] [Abstract][Full Text] [Related]
14. Struma ovarii maligna.
Matysiak-Grzes M; Fischbach J; Gut P; Klimowicz A; Gryczynska M; Wasko R; Ruchala M
Neuro Endocrinol Lett; 2013; 34(2):97-101. PubMed ID: 23645304
[TBL] [Abstract][Full Text] [Related]
15. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
Mazzaferri EL; Kloos RT
J Clin Endocrinol Metab; 2002 Apr; 87(4):1490-8. PubMed ID: 11932270
[TBL] [Abstract][Full Text] [Related]
16. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
[TBL] [Abstract][Full Text] [Related]
17. [Intravenous or oral 131I treatment of hyperthyroidism and thyroid cancer?].
Müller KD; Grebe SF; Bock FL; Müller H; Fängewisch GL
Nuklearmedizin; 1994 Jun; 33(3):87-92. PubMed ID: 8090631
[TBL] [Abstract][Full Text] [Related]
18. Radioiodine remnant ablation in differentiated thyroid cancer after combined endogenous and exogenous TSH stimulation.
Vrachimis A; Schober O; Riemann B
Nuklearmedizin; 2012; 51(3):67-72. PubMed ID: 22294096
[TBL] [Abstract][Full Text] [Related]
19. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement.
Spencer CA; LoPresti JS; Fatemi S; Nicoloff JT
Thyroid; 1999 May; 9(5):435-41. PubMed ID: 10365673
[TBL] [Abstract][Full Text] [Related]
20. Malignant teratoma of the thyroid: case report.
Martins T; Carrilho F; Gomes L; Mesquita C; Martins MJ; Carvalheiro M
Thyroid; 2006 Dec; 16(12):1311-3. PubMed ID: 17199442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]